PACS Group, Inc.

NYSE:PACS

Financial - Conglomerates

Financial Services
$46.30 +1.16%

+$0.41 today

Market cap
$7.35B
Beta
0.00
P/E (TTM)
23.0
EPS (TTM)
$1.55
52W Low $7.50High $43.08

Volume 0.78M

Average 0.84M

PACS Capital Expenditures

Cash spent on property, plant, equipment, and other long-term assets.

PACS Group, Inc.NYSE: PACS

Capital Expenditures · Q2 FY2026 · quarter ended Jun 2026

Capital expenditures growth accelerates

Q2 FY2026 capital expenditures of $26.53M (cash outflow) rose 42.8% year over year, ahead of the -36.6% change in trailing-twelve-month capital expenditures. Sequentially, it rose 21.5% from the prior quarter. Over 3 fiscal years it compounded at +66.4% a year.

Context

  • Capital expenditures amounted to 2.0% of revenue in FY2025, down 6.6 pp from a year earlier.
  • Capital expenditures grew in size in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +42.8% holds above the trailing-twelve-month pace of -36.6%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
-$26.53M+21.5% QoQ
Last fiscal yearDec 2025
-$105.41M-69.9% YoY
LTMJun 2026
-$117.47M-36.6% YoY
Capital Expenditures past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+42.8%——
1 year-69.9%——
3-year CAGR+66.4%——
5-year CAGR——
10-year CAGR——

Capital Expenditures history

USD · from the cash flow

Latest · FY2025
(105.41M) USD
Year-over-year change
+69.9%

Capital Expenditures vs competitors

How PACS compares with its peers on the latest reported figures

  • PACS's LTM Jun 2026 capital expenditures of $117.47M is the 6th largest of the 11 companies compared; the peer median is $117.69M.
  • Its year-over-year change of -36.6% is the 10th highest of 11, against a peer median of +16.3%.
  • Capital expenditures amounts to 2.1% of revenue for PACS, versus a peer median of 2.4%.
PACS Competitors Peer median
Capital Expenditures for PACS and competitors
Company Period LTM YoY 3-year CAGR% of revenue
HCAHCA Healthcare, Inc.LTM Jun 2026$5.13B +10.4%+4.0%6.6%
EHCEncompass Health CorporationLTM Jun 2026$799.1M +19.9%+8.0%12.9%
CYHCommunity Health Systems, Inc.LTM Mar 2026$326M -7.4%-6.9%1.5%
BKDBrookdale Senior Living Inc.LTM Sep 2026$217.71M +15.7%+0.8%7.4%
ENSGThe Ensign Group, Inc.LTM Jun 2026$189.34M +1.7%+30.3%3.5%
PACSPACS Group, Inc.LTM Jun 2026$117.47M -36.6%+66.4%2.1%
NHCNational HealthCare CorporationLTM Sep 2026$46.05M +34.6%+6.5%2.9%
PNTGThe Pennant Group, Inc.LTM Mar 2026$18.77M +113.1%+15.8%1.8%
INNVInnovAge Holding Corp.LTM Mar 2026$11.39M +16.8%-45.3%1.2%
LFSTLifeStance Health Group, Inc.LTM Jun 2026$7.84M -70.2%-23.0%0.5%
NUTXNutex Health, Inc.LTM Mar 2026$3.66M +124.1%-44.3%0.4%
Peer median (excluding PACS) $117.69M+16.3%+2.4%2.4%

Competitors are the stored peer set for PACS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income47.95M150.5M112.87M55.76M191.46M
Depreciation & Amortization7.15M22.31M25.63M40.81M55.66M
Deferred Income Tax7.83M(1.92M)(9.92M)(44.48M)(17.73M)
Stock-Based Compensation000115.54M54.07M
Change in Working Capital(4.36M)(94.29M)(94.66M)158.22M72.71M
Accounts Receivables(40.09M)(114.62M)(179.94M)(116.46M)14.43M
Inventory00000
Accounts Payables30.78M32.81M33.37M33.4M14.86M
Other Working Capital4.95M(12.48M)51.91M241.27M43.43M
Other Non-Cash Items(975K)16.02M29.78M41.5M48.05M
Operating Cash Flow57.6M92.62M63.7M367.34M404.22M
Capital Expenditures(124.09M)(22.86M)(45.78M)(349.81M)(105.41M)
Acquisitions (Net)(79.68M)(55.37M)(127.02M)(32.89M)(143M)
Purchases of Investments(15.71M)0(2.6M)(90.87M)(21.21M)
Sales of Investments877K01.86M25.87M5.59M
Other Investing Activities02.92M750K5.02M0
Investing Cash Flow(218.6M)(75.32M)(172.79M)(442.68M)(264.03M)
Debt Repayment235.85M69.38M209.4M(325.15M)(60.22M)
Common Stock Issued000509.44M0
Common Stock Repurchased00000
Dividends Paid(53.8M)(60.28M)(80.39M)(33.72M)0
Other Financing Activities03.25M587K(33.1M)(8.77M)
Financing Cash Flow182.05M12.35M129.59M117.48M(68.99M)
Effect of Forex Changes00000
Net Change in Cash21.05M29.64M20.5M42.14M71.21M
Free Cash Flow(66.49M)69.75M17.92M17.53M298.82M

PACS Group, Inc.

NYSE:PACS

Intrinsic Alpha fair value

Locked

Current Price

$46.30

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.